In contrast, and of particular interest, ablation of PIP5K1c in adipocytes in mice fed a HFD ameliorates metabolic abnormalities, including decreased fasting blood glucose levels, improved insulin sensitivity, ameliorated glucose intolerance and ameliorated fatty liver. Here, INS is linked to fatty liver disease.